Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Peter A. Johansson
Correction To: Prolonged Stable Disease in a Uveal Melanoma Patient With Germline MBD4 Nonsense Mutation Treated With Pembrolizumab and Ipilimumab
Immunogenetics
Immunology
Genetics
Related publications
Panhypopituitarism in Metastatic Melanoma Patient Treated With Ipilimumab and Pembrolizumab
Journal of Cutaneous Immunology and Allergy
Severe Hemophagocytic Lymphohistiocytosis in a Melanoma Patient Treated With Ipilimumab + Nivolumab
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Scalp Melanoma Treated With Ipilimumab in Elderly Patient: A Complete Response to Treatment—Case Report
Journal of Pharmacy and Pharmacology
Fatal Myocarditis and Rhabdomyositis in a Patient With Stage IV Melanoma Treated With Combined Ipilimumab and Nivolumab
Current Oncology
Oncology
Prolonged Benefit From Ipilimumab Correlates With Improved Outcomes From Subsequent Pembrolizumab
Cancer immunology research
Cancer Research
Immunology
Pneumocystis Jirovecii Pneumonia in a Patient With Melanoma Treated With Infliximab and Corticosteroids for Ipilimumab-Associated Colitis
Global Dermatology
Adjuvant Ipilimumab in High-Risk Uveal Melanoma
Cancers
Cancer Research
Oncology
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient With Metastatic Melanoma, Psoriasis, and a Previous Guillain–Barré Syndrome
Case Reports in Oncological Medicine
Oncology
Response to Pembrolizumab in a Heavily Treated Patient With Metastatic Ovarian Carcinosarcoma
Gynecologic Oncology Research and Practice
